Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company have led a USD 156m Series B funding round for biotechnology business Quell Therapeutics.
Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company have led a USD 156m Series B funding round for biotechnology business Quell Therapeutics.